Details for New Drug Application (NDA): 075252
✉ Email this page to a colleague
The generic ingredient in AZASAN is azathioprine. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the azathioprine profile page.
Summary for 075252
Tradename: | AZASAN |
Applicant: | Aaipharma Llc |
Ingredient: | azathioprine |
Patents: | 0 |
Pharmacology for NDA: 075252
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for 075252
Suppliers and Packaging for NDA: 075252
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AZASAN | azathioprine | TABLET;ORAL | 075252 | ANDA | Golden State Medical Supply, Inc. | 51407-182 | 51407-182-01 | 100 TABLET in 1 BOTTLE (51407-182-01) |
AZASAN | azathioprine | TABLET;ORAL | 075252 | ANDA | Salix Pharmaceuticals | 65649-231 | 65649-231-41 | 100 TABLET in 1 BOTTLE (65649-231-41) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Jun 7, 1999 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Feb 3, 2003 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 75MG | ||||
Approval Date: | Feb 3, 2003 | TE: | AB | RLD: | No |
Complete Access Available with Subscription